Novartis loses a Glivec patent case in Turkey Turkish IP News December 28, 2018 EPO, European patent, Gleevec, Glivec, imatinib mesylat, Novartis, Pharmaceutical, Turkish Constitutional Court No comments The Turkish Constitutional Court has ruled that there has been no violation of the property rights due to the invalidation of one of "Glivec®" patents of Novartis in Turkey. The Swiss pharmaceutical giant Novartis filed an international patent... Share: Read More